Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківський Національний Медичний УніверситетfiledCriticalХарківський Національний Медичний Університет
Priority to UAU201311666UpriorityCriticalpatent/UA87683U/en
Publication of UA87683UpublicationCriticalpatent/UA87683U/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
A method for diagnostics of left ventricle diastolic dysfunction in patients with hypertonic disease includes the determination of concentration of blood interleukins. Concentration of interleukin 33 and triglycerides of blood are determined, and at decreased concentration of interleukin 33, lower than 68 pg/ml, at level of triglycerides of 1.4 mmol/l and above the development of left ventricle diastolic dysfunction in patients with hypertonic disease is diagnosed.
UAU201311666U2013-10-032013-10-03Method for diagnostics of left ventricle diastolic dysfunction in patients with hypertonic disease
UA87683U
(en)
Method for diagnostics of severity of cardiac insufficiency with remained ejection fraction in patients affected by cardiac infarction at background of arterial hypertension
Method for diagnostics of development of cardiac complications in patients with hypertrophy of left ventricle of heart at combined course of hypertonic disease and 2 type diabetes mellitus
Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of azelnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Usefulness of Magnetic Resonance Cholangiopancreatography and Intraoperative Cholangiography in Detection of Biliary Variants in Children with Choledochal Cysts
METHOD FOR DETERMINING THE PREDICTOR SIGNIFICANCE OF BRAIN SODIURETIC PEPTIDE IN PATIENTS WITH CHRONIC KIDNEY DISEASE, GETTING THERAPY WITH PROGRAM HEMODIALYSIS